GABRP has been reported to play an immunomodulatory role in pancreatic cancer in a neurotransmitter independent manner, promoting macrophage infiltration by inducing the expression of CXCL5 and CCL20, and thereby affecting tumor growth and metastasis (Jiang et al., 2019). This evidence concerns the gene CXCL5 and neoplasm.